Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge
OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Yeungnam Med Sci > Volume 5(2); 1988 > Article
Original Article The Bronchodilatory Effect of Ipratropium Bromide on Bronchial Asthma.
Jae Hee Ahn, Tae Nyeon Kim, Young Hyeun Lee, Jae Chun Chung, Hyun Woo Lee
Journal of Yeungnam Medical Science 1988;5(2):95-100
DOI: https://doi.org/10.12701/yujm.1988.5.2.95
Published online: December 31, 1988
  • 1,477 Views
  • 3 Download
  • 0 Crossref
  • 0 Scopus

Ipratropium bromide (IP) is a new anticholinergic bronchodilator. To evaluate its effect on bronchial asthma which is still unknown in Korea, a double blind and randomized study was done on all patients of bronchial asthma who visit out-patients clinic of out department from June to September 197 and showed 75 to 100% of FEV1/FVC ratio on prebronchodilator spirometry (pre BD). The selected patients were given 2 puffs of Fenoterol (FE) or Ipratropium inhalator blindly and Spirometry. The repeated results are: 1. In both FE and IP groups, there was a significant bronchodilatory effect on 5 and 60 minutes after administration. 2. One 5 minutes, effect of FE was significantly greater than IP (FVC p<0.05, FEV1 p<0.01). 3. One 60 minutes, effect of IP was slightly less than FE but statistically non-significant. On the basis of above results, we concluded that onset of effect of IP is slower than FE, but its effect is significant and nearly comparable to FE.

Related articles

JYMS : Journal of Yeungnam Medical Science